NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
InspireMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.44−0.02 (-3.34%)
Close on Oct 19, 2026
- Market cap
- $37.25M
- P/E (TTM)
- –
- Dividend yield
- –
InspireMD, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries [Member] | $4.89M | $4.44M | $4.06M | $3.59M | $3.27M | $3.58M | $3.42M | $3.97M | $3.80M | $3.79M | $3.38M | $3.01M | 45.1% | +49.4% |
| U.S. [Member] | $2.19M | $2.57M | $1.42M | $554.00K | $64.00K | – | $32.00K | – | – | – | – | – | 20.2% | +3321.9% |
| Italy | $1.31M | $1.33M | $1.23M | $1.24M | $1.25M | $1.19M | $1.22M | $1.13M | $1.15M | $1.22M | $1.20M | $1.19M | 12.0% | +4.4% |
| Germany | $1.15M | $1.25M | $1.23M | $1.05M | $979.00K | $926.00K | $926.00K | $1.05M | $955.00K | $924.00K | $896.00K | $699.00K | 10.6% | +17.6% |
| Poland | $1.12M | $1.11M | $1.04M | $846.00K | $811.00K | $769.00K | $694.00K | – | – | – | – | – | 10.4% | +38.6% |
| Russia | – | – | – | – | – | – | $713.00K | – | – | – | $738.00K | – | – | – |
From the segment and revenue-disaggregation notes of InspireMD's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.